Cargando…

Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study

BACKGROUND: Congenital diaphragmatic hernia is a severe congenital anomaly with significant mortality and morbidity, for instance chronic lung disease. Sphingolipids have shown to be involved in lung injury, but their role in the pathophysiology of chronic lung disease has not been explored. We hypo...

Descripción completa

Detalles Bibliográficos
Autores principales: Snoek, Kitty G., Reiss, Irwin K. M., Tibboel, Jeroen, van Rosmalen, Joost, Capolupo, Irma, van Heijst, Arno, Schaible, Thomas, Post, Martin, Tibboel, Dick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861280/
https://www.ncbi.nlm.nih.gov/pubmed/27159222
http://dx.doi.org/10.1371/journal.pone.0155136
_version_ 1782431195597897728
author Snoek, Kitty G.
Reiss, Irwin K. M.
Tibboel, Jeroen
van Rosmalen, Joost
Capolupo, Irma
van Heijst, Arno
Schaible, Thomas
Post, Martin
Tibboel, Dick
author_facet Snoek, Kitty G.
Reiss, Irwin K. M.
Tibboel, Jeroen
van Rosmalen, Joost
Capolupo, Irma
van Heijst, Arno
Schaible, Thomas
Post, Martin
Tibboel, Dick
author_sort Snoek, Kitty G.
collection PubMed
description BACKGROUND: Congenital diaphragmatic hernia is a severe congenital anomaly with significant mortality and morbidity, for instance chronic lung disease. Sphingolipids have shown to be involved in lung injury, but their role in the pathophysiology of chronic lung disease has not been explored. We hypothesized that sphingolipid profiles in tracheal aspirates could play a role in predicting the mortality/ development of chronic lung disease in congenital diaphragmatic hernia patients. Furthermore, we hypothesized that sphingolipid profiles differ between ventilation modes; conventional mechanical ventilation versus high-frequency oscillation. METHODS: Sphingolipid levels in tracheal aspirates were determined at days 1, 3, 7 and 14 in 72 neonates with congenital diaphragmatic hernia, born after > 34 weeks gestation at four high-volume congenital diaphragmatic hernia centers. Data were collected within a multicenter trial of initial ventilation strategy (NTR 1310). RESULTS: 36 patients (50.0%) died or developed chronic lung disease, 34 patients (47.2%) by stratification were initially ventilated by conventional mechanical ventilation and 38 patients (52.8%) by high-frequency oscillation. Multivariable logistic regression analysis with correction for side of the defect, liver position and observed-to-expected lung-to-head ratio, showed that none of the changes in sphingolipid levels were significantly associated with mortality /development of chronic lung disease. At day 14, long-chain ceramides 18:1 and 24:0 were significantly elevated in patients initially ventilated by conventional mechanical ventilation compared to high-frequency oscillation. CONCLUSIONS: We could not detect significant differences in temporal sphingolipid levels in congenital diaphragmatic hernia infants with mortality/development of chronic lung disease versus survivors without development of CLD. Elevated levels of ceramides 18:1 and 24:0 in the conventional mechanical ventilation group when compared to high-frequency oscillation could probably be explained by high peak inspiratory pressures and remodeling of the alveolar membrane.
format Online
Article
Text
id pubmed-4861280
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-48612802016-05-13 Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study Snoek, Kitty G. Reiss, Irwin K. M. Tibboel, Jeroen van Rosmalen, Joost Capolupo, Irma van Heijst, Arno Schaible, Thomas Post, Martin Tibboel, Dick PLoS One Research Article BACKGROUND: Congenital diaphragmatic hernia is a severe congenital anomaly with significant mortality and morbidity, for instance chronic lung disease. Sphingolipids have shown to be involved in lung injury, but their role in the pathophysiology of chronic lung disease has not been explored. We hypothesized that sphingolipid profiles in tracheal aspirates could play a role in predicting the mortality/ development of chronic lung disease in congenital diaphragmatic hernia patients. Furthermore, we hypothesized that sphingolipid profiles differ between ventilation modes; conventional mechanical ventilation versus high-frequency oscillation. METHODS: Sphingolipid levels in tracheal aspirates were determined at days 1, 3, 7 and 14 in 72 neonates with congenital diaphragmatic hernia, born after > 34 weeks gestation at four high-volume congenital diaphragmatic hernia centers. Data were collected within a multicenter trial of initial ventilation strategy (NTR 1310). RESULTS: 36 patients (50.0%) died or developed chronic lung disease, 34 patients (47.2%) by stratification were initially ventilated by conventional mechanical ventilation and 38 patients (52.8%) by high-frequency oscillation. Multivariable logistic regression analysis with correction for side of the defect, liver position and observed-to-expected lung-to-head ratio, showed that none of the changes in sphingolipid levels were significantly associated with mortality /development of chronic lung disease. At day 14, long-chain ceramides 18:1 and 24:0 were significantly elevated in patients initially ventilated by conventional mechanical ventilation compared to high-frequency oscillation. CONCLUSIONS: We could not detect significant differences in temporal sphingolipid levels in congenital diaphragmatic hernia infants with mortality/development of chronic lung disease versus survivors without development of CLD. Elevated levels of ceramides 18:1 and 24:0 in the conventional mechanical ventilation group when compared to high-frequency oscillation could probably be explained by high peak inspiratory pressures and remodeling of the alveolar membrane. Public Library of Science 2016-05-09 /pmc/articles/PMC4861280/ /pubmed/27159222 http://dx.doi.org/10.1371/journal.pone.0155136 Text en © 2016 Snoek et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Snoek, Kitty G.
Reiss, Irwin K. M.
Tibboel, Jeroen
van Rosmalen, Joost
Capolupo, Irma
van Heijst, Arno
Schaible, Thomas
Post, Martin
Tibboel, Dick
Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study
title Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study
title_full Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study
title_fullStr Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study
title_full_unstemmed Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study
title_short Sphingolipids in Congenital Diaphragmatic Hernia; Results from an International Multicenter Study
title_sort sphingolipids in congenital diaphragmatic hernia; results from an international multicenter study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861280/
https://www.ncbi.nlm.nih.gov/pubmed/27159222
http://dx.doi.org/10.1371/journal.pone.0155136
work_keys_str_mv AT snoekkittyg sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy
AT reissirwinkm sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy
AT tibboeljeroen sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy
AT vanrosmalenjoost sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy
AT capolupoirma sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy
AT vanheijstarno sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy
AT schaiblethomas sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy
AT postmartin sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy
AT tibboeldick sphingolipidsincongenitaldiaphragmaticherniaresultsfromaninternationalmulticenterstudy